Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Dacomitinib> ?p ?o. }
Showing items 1 to 26 of
26
with 100 items per page.
- Dacomitinib abstract "Dacomitinib (PF-00299804) is an experimental drug candidate under development by Pfizer for the treatment of non-small-cell lung carcinoma. It is a selective and irreversible inhibitor of EGFR.Dacomitinib has advanced to several Phase III clinical trials. The results of the first trials were disappointing, with a failure to meet the study goals, Additional Phase III trials are ongoing.".
- Dacomitinib iupacName "(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl}-4-(1-piperidinyl)-2-butenamide".
- Dacomitinib thumbnail Dacomitinib.svg?width=300.
- Dacomitinib wikiPageExternalLink dacomitinib_fact_sheet.pdf.
- Dacomitinib wikiPageID "42046572".
- Dacomitinib wikiPageRevisionID "604135509".
- Dacomitinib imagefile "Dacomitinib.svg".
- Dacomitinib imagesize "200".
- Dacomitinib iupacname "-N-{4-[amino]-7-methoxy-6-quinazolinyl}-4--2-butenamide".
- Dacomitinib othernames "PF-00299804".
- Dacomitinib subject Category:Anilines.
- Dacomitinib subject Category:Experimental_cancer_drugs.
- Dacomitinib subject Category:Piperidines.
- Dacomitinib subject Category:Quinazolines.
- Dacomitinib type ChemicalCompound.
- Dacomitinib type ChemicalSubstance.
- Dacomitinib type ChemicalObject.
- Dacomitinib type Thing.
- Dacomitinib comment "Dacomitinib (PF-00299804) is an experimental drug candidate under development by Pfizer for the treatment of non-small-cell lung carcinoma. It is a selective and irreversible inhibitor of EGFR.Dacomitinib has advanced to several Phase III clinical trials. The results of the first trials were disappointing, with a failure to meet the study goals, Additional Phase III trials are ongoing.".
- Dacomitinib label "Dacomitinib".
- Dacomitinib sameAs m.0_vbh7h.
- Dacomitinib sameAs Q17130597.
- Dacomitinib sameAs Q17130597.
- Dacomitinib wasDerivedFrom Dacomitinib?oldid=604135509.
- Dacomitinib depiction Dacomitinib.svg.
- Dacomitinib isPrimaryTopicOf Dacomitinib.